Disease Control

Aciont Inc.
John Higuchi
Envisioning the Future of Ocular Therapeutics

Aciont description: Aciont™ Inc. endeavors to become the world leader in commercializing localized, non-invasive and controlled release back-of-the-eye therapeutics for sight threatening diseases. Our name Aciont (“action transport therapeutics”) refers to our expertise in controlling drug transport through human membrane tissues. Our Visulex™ technology provides ophthalmologists (and potentially patients themselves) substantially greater freedom in treating and/or preventing chronic eye diseases through superior drug dosing control and improved patient/physician compliance.